Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Lower

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer..

The Dow Jones Industrial Average ( ^DJI) is trading down 136.0 points (-0.8%) at 17,903 as of Friday, Jun 12, 2015, 1:36 p.m. ET. During this time, 153.9 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 353.6 million. The NYSE advances/declines ratio sits at 1,079 issues advancing vs. 1,908 declining with 157 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Holding back the Dow today is Johnson & Johnson (NYSE: JNJ), which is lagging the broader Dow index with an 80-cent decline (-0.8%) bringing the stock to $98.44. This single loss is lowering the Dow Jones Industrial Average by 6.05 points or roughly accounting for 4.4% of the Dow's overall loss. Volume for Johnson & Johnson currently sits at 4.1 million shares traded vs. an average daily trading volume of 7.8 million shares.

Johnson & Johnson has a market cap of $274.2 billion and is part of the health care sector and drugs industry. Shares are down 5.1% year-to-date as of Thursday's close. The stock's dividend yield sits at 3%.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.

TheStreet Ratings rates Johnson & Johnson as a buy. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE..

More from Markets

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Aceto's Search for Deal May Be Slowed by DOJ Subpoena

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Dow and S&P 500 Finish Higher Amid Strong Corporate Earnings

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Veteran Foreign Affairs Expert Ian Bremmer Reveals How to Price Political Risk

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

Investors Shouldn't Be Worried About Trump's Trade Tariffs: Ian Bremmer

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists